Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002800.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Bad
0%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -10.85 2.48 2.79
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 2593.66 2.50 0.09
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.75 4.76 4.72
Cash 6.25 1.67 1.58
Capex -460.43 < 0.005 < 0.005
Free Cash Flow -61.84 0.04 -0.10
Revenue 0.74 1.57 1.56
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -26.22 0.07 0.10
Operating Margin -65.26 0.04 -0.11
ROA -93.97 < 0.005 -0.07
ROE -93.63 < 0.005 -0.12
ROIC -66.55 < 0.005 -0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002800.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002800.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002800.SZ is permitted for members.